Clearside Biomedical's market cap is currently ―. The company's EPS TTM is $-0.526; its P/E ratio is -2.60; Clearside Biomedical is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 859.00K	$ 1.02M	$ 4.00K	$ 330.00K	$ 266.00K
Gross Profit	$ 717.00K	$ 805.00K	$ 4.00K	$ 330.00K	-
EBIT	$ -6.64M	$ -6.81M	$ -7.11M	$ -8.92M	$ -6.53M
EBITDA	$ -6.63M	$ -6.80M	$ -7.10M	$ -8.90M	$ -6.49M
Net Income Common Stockholders	$ -9.27M	$ -9.11M	$ -9.28M	$ -12.26M	$ -7.83M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 28.80M	$ 35.00M	$ 41.40M	$ 48.30M	$ 53.38M
Total Assets	$ 34.42M	$ 39.18M	$ 44.70M	$ 51.30M	$ 55.69M
Total Debt	$ 1.09M	$ 1.16M	$ 1.22M	$ 1.28M	$ 407.00K
Net Debt	$ -27.71M	$ -33.84M	$ -40.18M	$ -47.02M	$ -52.97M
Total Liabilities	$ 47.27M	$ 44.16M	$ 41.99M	$ 40.70M	$ 37.14M
Stockholders Equity	$ -12.85M	$ -4.97M	$ 2.70M	$ 10.61M	$ 18.55M
Cash Flow	-
Free Cash Flow	$ -6.52M	$ -6.44M	$ -7.33M	$ -5.70M	$ -6.34M
Operating Cash Flow	$ -6.08M	$ -5.34M	$ -7.22M	$ -5.61M	$ -6.19M
Investing Cash Flow	$ -445.00K	$ -1.10M	$ -115.00K	$ -91.00K	$ -155.00K
Financing Cash Flow	$ 317.00K	$ 22.00K	$ 332.00K	$ 575.00K	$ 30.69M

Currency in USD

Clearside Biomedical Earnings and Revenue History

Income Statement >

Clearside Biomedical Debt to Assets

Balance Sheet >

Clearside Biomedical Cash Flow

Cash Flow >

Clearside Biomedical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing